Clinical Trial

Indocyanine Green Fluorescence Angiography in Laparoscopic Sigmoid and Rectal Cancer Surgery

Completed
View on ClinicalTrials.gov →
Summary
Anastomotic leakage remains a major complication after colorectal cancer surgery. Indocyanine green fluorescence angiography (ICG-FA) allows real-time intraoperative assessment of bowel perfusion; however, its clinical impact remains controversial. This prospective single-center observational study evaluated the association between intraoperative use of ICG-FA and postoperative outcomes in patients undergoing laparoscopic sigmoid or rectal cancer surgery. Outcomes of patients assessed with ICG-FA were compared with those of a historical control cohort treated without fluorescence imaging.
Trial Details
NCT Number NCT07423130
Lead Sponsor Jagiellonian University
Conditions Colorectal Cancer (CRC), Rectal Cancer Surgery, Sigmoid Colon Cancer
Enrollment 115 participants
Start Date 2023-10-09
Primary Completion 2025-02-15 (estimated)
Study Completion 2025-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-20